International Immunopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.6 | Q1 | 84.8% | 1.354 | Q1 | 90.3% |
| 2024 | 4.7 | Q1 | 85.0% | 1.239 | Q1 | 89.0% |
| 2023 | 4.8 | Q1 | 85.8% | 1.167 | Q1 | 88.8% |
| 2022 | 5.6 | Q1 | 86.6% | 1.100 | Q1 | 88.3% |
| 2021 | 5.7 | Q1 | 83.6% | 1.059 | Q1 | 87.7% |
| 2020 | — | — | 1.152 | Q1 | 88.2% | |
| 2019 | — | — | 0.992 | Q1 | 85.4% | |
| 2018 | — | — | 0.953 | Q2 | 83.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1567-5769
ISSN
1878-1705
country
NLcoverage
2001-2026